Rubicon Research Limited (RUBICON) — Announcement
· NSE
🔴 High Importance
Neutral
No summary available
About Rubicon Research Limited (RUBICON)
Healthcare · Pharmaceuticals & Biotechnology · Listed on NSE
Market Cap: ₹15,864.53 Cr
📡 Get AI alerts when RUBICON files next
Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions
Track RUBICON — Free💡 Ask AI about this filing
"How does this announcement affect Rubicon Research Limited's outlook?"
"What did Rubicon Research Limited announce on 19 June 2026?"
"Is this positive or negative for RUBICON?"
Ask AI Free →
📊 More RUBICON filings
- Announcement — 20 July 2026 Rubicon Research Limited announced on July 20, 2026, that its Nomination and Remuneration Committee ...
- Announcement — 3 July 2026 Rubicon Research Limited disclosed that the US FDA conducted an unannounced inspection of its newly ...
- Financial Results — 29 June 2026 Rubicon Research Limited announced that its trading window will close on July 1, 2026, ahead of the ...
- 🔴 Announcement — 10 June 2026 No summary available
- 🔴 Financial Results — 2 June 2026 Rubicon Research reported Q4 FY26 revenue of **₹5,139 crores**, up 44% YoY, with PAT rising 112% to ...
🔥 Also filed on 19 June 2026
PRECAM
Precision Camshafts Limited
Financial Results
PTL
PTL Enterprises Limited
Corporate Action
PRESTIGE
Prestige Estates Projects Limited
Offer Document
PURVA
Puravankara Limited
Announcement
PVP
PVP Ventures Limited
Announcement
QUICKHEAL
Quick Heal Technologies Limited
Announcement
View all today's announcements →
Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.
📡 Get AI alerts when RUBICON files new disclosures
Track RUBICON filings, board meetings, and corporate actions. Free email alerts at 5 PM.
Track RUBICON — FreeFree account · 2 AI queries/day
© 2026 StockFin.ai — AI-powered Indian stock research